pemafibrate
Kowa Pharmaceuticals
[]
prominent randomized &gt;10k pts 1/4 women to pemafibrate .2mg bid for high triglycerides 200-499 or hdl &lt;=40 in dm2 (no dm1) placebo neutral primary endpoint hr 1.03 no dif in pre specified subgroups renal adverse,v embolism nalfd #aha22 
AssistProfessor #cardiologist #SoMe #editor @CircOutcomes & @JournalASEcho #BOD @ase360 #ACCWIC @PittHealthSci #MedHumanities @ColumbiaMed @NUFeinbergMed